ITGAL As a Prognostic Biomarker Correlated with Immune Infiltrates in Melanoma
Overview
Affiliations
This study investigates the relationship between ITGAL expression and immune infiltration, clinical prognosis, and specific types of T cells in melanoma tissue. The findings reveal the key role of ITGAL in melanoma and its potential mechanism of regulating tumor immune infiltrating cells, highlighting its potential as a diagnostic biomarker and therapeutic target for advanced melanoma.
Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer.
Lin F, Yang H, Huang Z, Li Y, Ding Q, Ye Y Front Pharmacol. 2024; 15:1464830.
PMID: 39605903 PMC: 11598444. DOI: 10.3389/fphar.2024.1464830.
ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.
Zhang R, Zhu G, Li Z, Meng Z, Huang H, Ding C Front Immunol. 2024; 15:1382231.
PMID: 38646528 PMC: 11027504. DOI: 10.3389/fimmu.2024.1382231.